Suppr超能文献

全身麻醉药是通过与特定受体竞争性结合起作用的吗?

Do general anaesthetics act by competitive binding to specific receptors?

作者信息

Franks N P, Lieb W R

出版信息

Nature. 1984;310(5978):599-601. doi: 10.1038/310599a0.

Abstract

Most proteins are insensitive to the presence of anaesthetics at concentrations which induce general anaesthesia, while some are inhibited by certain agents but not others. Here we show that, over a 100,000-fold range of potencies, the activity of a pure soluble protein (firefly luciferase) can be inhibited by 50% at anaesthetic concentrations which are essentially identical to those which anaesthetize animals. This identity holds for inhalational agents (such as halothane, methoxyflurane and chloroform), aliphatic and aromatic alcohols, ketones, ethers and alkanes. This finding is all the more striking in view of the fact that the inhibition is shown to be competitive in nature, with anaesthetic molecules competing with substrate (luciferin) molecules for binding to the protein. We show that the anaesthetic-binding site can accommodate only one large, but more than one small, anaesthetic molecule. The obvious mechanism suggested by our results is that general anaesthetics, despite their chemical and structural diversity, act by competing with endogenous ligands for binding to specific receptors.

摘要

大多数蛋白质在诱导全身麻醉的浓度下对麻醉剂的存在不敏感,而有些蛋白质会被某些药剂抑制,但不会被其他药剂抑制。在此我们表明,在超过10万倍的效力范围内,一种纯可溶性蛋白质(萤火虫荧光素酶)的活性在麻醉浓度下可被抑制50%,这些麻醉浓度与麻醉动物的浓度基本相同。这种一致性适用于吸入性药剂(如氟烷、甲氧氟烷和氯仿)、脂肪族和芳香族醇类、酮类、醚类和烷烃。鉴于这种抑制作用本质上是竞争性的,麻醉剂分子与底物(荧光素)分子竞争与蛋白质结合,这一发现就更加引人注目。我们表明,麻醉剂结合位点只能容纳一个大的麻醉剂分子,但能容纳不止一个小的麻醉剂分子。我们的结果所表明的明显机制是,全身麻醉剂尽管在化学和结构上具有多样性,但通过与内源性配体竞争结合特定受体来发挥作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验